Qualified Person on Demand: Flexible QP expertise for your batch release.

Flexible QP expertise exactly when you need it. Whether due to staff turnover, order spikes at CDMOs, or short-term vacancies—our “QP on Demand” service ensures your batch releases, GMP compliance, and project support.

What is QP on Demand? A Qualified Person (QP) as defined in Article 49 of EU Directive 2001/83/EC is responsible for the batch release of medicinal products. “QP on Demand” means: ENTOURAGE provides experienced, officially recognized Qualified Persons on short notice and with flexibility—for vacation cover, vacancies, capacity bottlenecks, or as a permanent external QP solution.

Use cases: When the need becomes acute.

Pharmaceutical companies, CDMOs and importers are familiar with the scenario: when workloads are high or there are sudden staff changes, the pressure on the internal organization increases. Batch releases in accordance with AMG, GMP guidelines and other regulatory requirements must still be carried out promptly in order to avoid delays and loss of sales. CDMOs in particular often reach their capacity limits when several customer projects have to be handled in parallel.

Our "QP on Demand" service is designed specifically for these situations. We provide QP expertise on short notice to ensure your compliance and enable the seamless continuation of your business operations.

Do you need a qualified person on short notice?

We handle temporary batch release for your company—in full compliance with legal requirements and GMP standards. Learn more about our comprehensive services on our official service page.

About our QP on Demand Service

What sets our "QP on Demand" service apart?

  • Immediate availability: We can provide you with experienced QPs within a few days.
  • Maximum flexibility: Tailored support for exactly as long as you need it—whether for a specific project or on an interim basis.
  • Technical Expertise: Our Qualified Persons meet all regulatory requirements under Section 15 of the German Medicines Act (AMG), Annex 16 of the EU GMP Guidelines, and the Clinical Trials Regulation (EU) No. 536/2014.
  • Cost-effectiveness: You avoid long-term commitments or additional personnel costs.

How does "QP on Demand" work at ENTOURAGE?

  • 01 — Needs Assessment: Define the product portfolio, dosage forms, manufacturing sites, and scope of approval.
  • 02 — QP Matching: Assign a suitable QP with relevant expertise and product experience from the ENTOURAGE pool.
  • 03 — Onboarding: Integrate the Qualified Person into existing processes: QMS, batch records, deviation handling.
  • 04 — Release: Ongoing batch release and GMP review. Documentation and assumption of responsibility.
  • 05 — Transition: If necessary: Handover to internal QP, including knowledge transfer and onboarding support.

When can you benefit most from "QP on Demand"?

  • If batch releases are required at short notice.
  • For staff shortages or interim solutions.
  • To ensure audit and inspection readiness.
  • For specific regulatory challenges and projects.

Recommendations for optimal cooperation.

  • Communicate your requirements at an early stage.
  • Clarify the precise scope of the support required in advance.
  • Plan regular coordination to ensure smooth integration into your processes.

"QP on Demand" from ENTOURAGE offers pharmaceutical companies, CDMOs, and importers exactly the flexibility and reliability that are crucial at critical moments. It ensures compliance, prevents production downtime, and provides access to expertise that minimizes regulatory risks.

Are you facing regulatory challenges in the near future?

Arrange a non-binding consultation appointment now

FAQ: Frequently Asked Questions About "QP on Demand"

What qualifications do our Qualified Persons have?
Our QPs meet all regulatory requirements for batch release in accordance with Section 15 AMG and Annex 16 of the EU GMP guidelines (Eudralex Volume 4), Article 51 of EU Directive 2001/83/EC, and the AMWHV (Sections 12, 16, 25). In addition, their qualifications meet the requirements of the Clinical Trials Regulation (EU) No. 536/2014, Article 62(1).
How quickly can a QP be provided?
In urgent cases, within 48–72 hours. For planned assignments (vacation cover, parental leave), we recommend 2–4 weeks’ notice to allow for a structured onboarding process.
Can an external qualified person legally approve products for my company?
Yes. An external QP can be contracted to act as your QP. To do so, they simply need to be officially registered with the relevant state authority. The QP is responsible for technical approval.
Is remote working possible?
Yes, many tasks such as document review or consulting can be carried out remotely. For specific tasks - especially final batch release - a physical presence or qualified electronic signature is required, depending on the location and regulatory framework.
How much does QP on Demand cost?
Costs are based on the scope and duration of the assignment. Individual project approvals are billed on a daily rate basis. We offer flat-rate pricing for interim assignments. Please contact us for a customized quote.
Are we maintaining control over our compliance processes?
Absolutely. Our QPs work with you as partners, while you retain full control and responsibility for your internal processes. The QP operates within the framework of your QMS.

Share this article.

Facebook
Twitter
LinkedIn
XING
WhatsApp
Email

Newsletter.

Read more.

Regulatory Intelligence: It’s not about finding the “best” tool.
There is no single best regulatory intelligence solution—only the one that...
How the Next Generation Supply Chain is emerging.
The modern supply chain is facing immense challenges such as increasing ...
"SOCIAL DISTANCING" - a "lesson learned" or a "learning lesson"?
The "Corona crisis" calls for tough measures. These include so-called non-pharmaceutical interventions, ...
The MDR and IVDR Transposed into National Law: What Was Predicted in 2019—and What Actually Happened.
In 2019, Entourage experts analyzed the implementation of the MDR and IVDR in ...
Gradual introduction of the regulation for in vitro diagnostic medical devices for "old" IVDD-CE-labeled products.
An extension of the transitional periods should increase the pressure on IVD manufacturers ...